- Report
- July 2026
- 130 Pages
North America
From €4203EUR$4,750USD£3,602GBP
- Report
- July 2026
- 80 Pages
Europe
From €4203EUR$4,750USD£3,602GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3185EUR$3,600USD£2,730GBP
- Report
- July 2025
- 200 Pages
Saudi Arabia
From €2203EUR$2,490USD£1,888GBP
- Report
- March 2025
- 200 Pages
Global
From €2203EUR$2,490USD£1,888GBP
- Report
- April 2025
- 134 Pages
Global
From €5265EUR$5,950USD£4,511GBP
- Report
- September 2024
- 110 Pages
Global
From €5265EUR$5,950USD£4,511GBP
- Report
- August 2025
- 193 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2025
- 189 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2025
- 197 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2025
- 182 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2025
- 180 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- March 2024
- 200 Pages
Global
From €3672EUR$4,150USD£3,147GBP
- Report
- March 2024
- 200 Pages
Global
From €3672EUR$4,150USD£3,147GBP
- Report
- January 2024
- 200 Pages
Global
From €3672EUR$4,150USD£3,147GBP
- Report
- August 2023
- 145 Pages
Global
From €2787EUR$3,150USD£2,388GBP
- Report
- August 2025
- 187 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2025
- 190 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2654EUR$3,000USD£2,275GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1106EUR$1,250USD£948GBP

Metformin is a drug used to treat endocrine and metabolic disorders, such as type 2 diabetes. It is a biguanide, a class of drugs that work by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin. Metformin is the most commonly prescribed drug for type 2 diabetes, and is also used to treat polycystic ovary syndrome and gestational diabetes. It is generally well-tolerated, with few side effects.
The Metformin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Teva Pharmaceuticals, Mylan, Sandoz, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin, and Aurobindo Pharma. Show Less Read more